STAT3-IN-12
STAT3-IN-12 is a potent STAT3 signal inhibitor that can inhibit IL-6 induced JAK/STAT3 signalling pathway activation. STAT3-IN-12 inhibits cancer cell growth, migration, and induce cell apoptosis as well as cycle arrest. STAT3-IN-12 can be used in cancer-related research, such as hepatocellular carcinoma (HCC) and oesophageal carcinoma[1].
Product Specifications
CAS Number
2980758-31-2
UNSPSC
12352005
Target
Apoptosis; STAT
Type
Reference compound
Related Pathways
Apoptosis; JAK/STAT Signaling; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/stat3-in-12.html
Concentration
10mM
Purity
99.87
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCCN1C2=C(C=C3C(N(CCC)C(C4=CC=CC(OC)=C4)=N3)=C2)N=C1C5=CC=CC(OC)=C5
Molecular Formula
C28H30N4O2
Molecular Weight
454.56
References & Citations
[1]Yi-Chen Liu, et al. Benzobis (imidazole) derivatives as STAT3 signal inhibitors with antitumor activity.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
STAT3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Aurora B (Proliferation Marker) (AURKB/1593), CF640R conjugate, 0.1mg/mL
![(S)-7-Amino-5H,7H-dibenzo[b,d]azepin-6-one](https://cdn.genprice.uk/products/572/3208900862299/imageurl/trc-a604380-2.5mg.webp)
(S)-7-Amino-5H,7H-dibenzo[b,d]azepin-6-one
